Literature DB >> 15888798

Clinical relevance of proteinase activated receptors (pars) in the gut.

N Vergnolle1.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 15888798      PMCID： PMC1774539          DOI： 10.1136/gut.2004.048876

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  52 in total

1.  Mast cell tryptase and proteinase-activated receptor 2 induce hyperexcitability of guinea-pig submucosal neurons.

Authors:  David E Reed; Carlos Barajas-Lopez; Graeme Cottrell; Sara Velazquez-Rocha; Olivier Dery; Eileen F Grady; Nigel W Bunnett; Stephen J Vanner
Journal:  J Physiol       Date:  2003-01-24       Impact factor: 5.182

2.  Modulation of Rho GTPase activity in endothelial cells by selective proteinase-activated receptor (PAR) agonists.

Authors:  V Vouret-Craviari; D Grall; E Van Obberghen-Schilling
Journal:  J Thromb Haemost       Date:  2003-05       Impact factor: 5.824

3.  Aberrant expression and activation of the thrombin receptor protease-activated receptor-1 induces cell proliferation and motility in human colon cancer cells.

Authors:  Dalila Darmoul; Valérie Gratio; Hélène Devaud; Thérèse Lehy; Marc Laburthe
Journal:  Am J Pathol       Date:  2003-05       Impact factor: 4.307

4.  Differential actions of PAR2 and PAR1 in stimulating human endothelial cell exocytosis and permeability: the role of Rho-GTPases.

Authors:  Scott W Klarenbach; Adam Chipiuk; Randy C Nelson; Morley D Hollenberg; Allan G Murray
Journal:  Circ Res       Date:  2003-02-21       Impact factor: 17.367

5.  Stimulation of proteinase-activated receptor 2 excites jejunal afferent nerves in anaesthetised rats.

Authors:  Anthony J Kirkup; Wen Jiang; Nigel W Bunnett; David Grundy
Journal:  J Physiol       Date:  2003-10-15       Impact factor: 5.182

6.  Evidence for the presence of functional protease activated receptor 4 (PAR4) in the rat colon.

Authors:  F Mulè; R Pizzuti; A Capparelli; N Vergnolle
Journal:  Gut       Date:  2004-02       Impact factor: 23.059

7.  Proteinase-activated receptor 1 activation induces epithelial apoptosis and increases intestinal permeability.

Authors:  Alex C Chin; Nathalie Vergnolle; Wallace K MacNaughton; John L Wallace; Morley D Hollenberg; Andre G Buret
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-05       Impact factor: 11.205

8.  Colitis induced by proteinase-activated receptor-2 agonists is mediated by a neurogenic mechanism.

Authors:  Cathy Nguyen; Anne-Marie Coelho; Eileen Grady; Steven J Compton; John L Wallace; Morley D Hollenberg; Nicolas Cenac; Rafael Garcia-Villar; Lionel Bueno; Martin Steinhoff; Nigel W Bunnett; Nathalie Vergnolle
Journal:  Can J Physiol Pharmacol       Date:  2003-09       Impact factor: 2.273

9.  PAR-2 agonists induce contraction of murine small intestine through neurokinin receptors.

Authors:  Aiping Zhao; Terez Shea-Donohue
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2003-06-11       Impact factor: 4.052

10.  Expression of protease-activated receptor 2 in ulcerative colitis.

Authors:  Jin-A Kim; Suck-Chei Choi; Ki-Jung Yun; Dae-Ki Kim; Myung-Kwan Han; Geom-Seog Seo; Ju-Jin Yeom; Tae-Hyun Kim; Yong-Ho Nah; Young-Mi Lee
Journal:  Inflamm Bowel Dis       Date:  2003-07       Impact factor: 5.325
View more
  48 in total

Review 1.  Targeting proteinase-activated receptors: therapeutic potential and challenges.

Authors:  Rithwik Ramachandran; Farshid Noorbakhsh; Kathryn Defea; Morley D Hollenberg
Journal:  Nat Rev Drug Discov       Date:  2012-01-03       Impact factor: 84.694

2.  Serine protease inhibition reduces post-ischemic granulocyte recruitment in mouse intestine.

Authors:  Thomas Gobbetti; Nicolas Cenac; Jean-Paul Motta; Corinne Rolland; Laurence Martin; Patricia Andrade-Gordon; Martin Steinhoff; Elisabetta Barocelli; Nathalie Vergnolle
Journal:  Am J Pathol       Date:  2011-11-07       Impact factor: 4.307

Review 3.  Proteinase-activated receptors in the lower urinary tract.

Authors:  James D Moffatt
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-02-10       Impact factor: 3.000

Review 4.  New insights into protease-activated receptor 4 signaling pathways in the pathogenesis of inflammation and neuropathic pain: a literature review.

Authors:  Yanju Bao; Yebo Gao; Liping Yang; Xiangying Kong; Honggang Zheng; Wei Hou; Baojin Hua
Journal:  Channels (Austin)       Date:  2015       Impact factor: 2.581

Review 5.  Human pancreatic digestive enzymes.

Authors:  David C Whitcomb; Mark E Lowe
Journal:  Dig Dis Sci       Date:  2007-01-05       Impact factor: 3.199

Review 6.  Proteinases and signalling: pathophysiological and therapeutic implications via PARs and more.

Authors:  R Ramachandran; M D Hollenberg
Journal:  Br J Pharmacol       Date:  2007-12-03       Impact factor: 8.739

7.  Protease-activated receptor-2 activation in gastric cancer cells promotes epidermal growth factor receptor trans-activation and proliferation.

Authors:  Roberta Caruso; Francesco Pallone; Daniele Fina; Valentina Gioia; Ilaria Peluso; Flavio Caprioli; Carmine Stolfi; Alessandra Perfetti; Luigi Giusto Spagnoli; Giampiero Palmieri; Thomas T Macdonald; Giovanni Monteleone
Journal:  Am J Pathol       Date:  2006-07       Impact factor: 4.307

Review 8.  Enteric bacterial proteases in inflammatory bowel disease- pathophysiology and clinical implications.

Authors:  Ian M Carroll; Nitsan Maharshak
Journal:  World J Gastroenterol       Date:  2013       Impact factor: 5.742

9.  Enterococcus faecalis Gelatinase Mediates Intestinal Permeability via Protease-Activated Receptor 2.

Authors:  Nitsan Maharshak; Eun Young Huh; Chorlada Paiboonrungruang; Michael Shanahan; Lance Thurlow; Jeremy Herzog; Zorka Djukic; Roy Orlando; Rafal Pawlinski; Melissa Ellermann; Luke Borst; Siten Patel; Iris Dotan; Ryan B Sartor; Ian M Carroll
Journal:  Infect Immun       Date:  2015-04-27       Impact factor: 3.441

Review 10.  Proteinases, proteinase-activated receptors (PARs) and the pathophysiology of cancer and diseases of the cardiovascular, musculoskeletal, nervous and gastrointestinal systems.

Authors:  Kristina K Hansen; Katerina Oikonomopoulou; Yang Li; Morley D Hollenberg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-10-19       Impact factor: 3.000
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.